DJIA 17,067.56 -30.89 -0.18%
NASDAQ 4,598.19 17.92 0.39%
S&P 500 2,002.28 -1.09 -0.05%
market minute promo

Nektar Therapeutics (NASDAQ: NKTR)

14.48 0.22 (1.54%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NKTR $14.48 1.54%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.40
Previous Close $14.26
Daily Range $14.16 - $14.55
52-Week Range $8.87 - $15.34
Market Cap $1.8B
P/E Ratio -12.08
Dividend (Yield) $0.00 (0.0%)
Volume 1,019,435
Average Daily Volume 1,096,124
Current FY EPS -$0.65

Sector

Healthcare

Industry

Drugs

Nektar Therapeutics (NKTR) Description

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines. Website: http://www.nektar.com/

News & Commentary Rss Feed

Can Anything Derail Salix Pharmaceuticals?

Expanded labeling for the sub-q form of Relistor could add $100 million in revenue, but doesn't change the business to a large extent

Nektar 181 Could Dominate A $13B Chronic Pain Market

Monday's ETF Movers: FBT, GDX

Positive Data on Baxter's Trial for BAX 855 - Analyst Blog

Positive Data on Baxter's Trial for BAX 855 - Analyst Blog

Nektar Therapeutics Has More To Give

Nektar Therapeutics Harnesses The Power Of AstraZeneca To Move Movantik

Nektar President Howard Robin Is Listening To You

Nektar's Loss Narrows in Q2, Beats Revenues, Retains View - Analyst Blog

Nektar's Loss Narrows in Q2, Beats Revenues, Retains View - Analyst Blog

Nektar Therapeutics' (NKTR) CEO Howard Robin on Q2 2014 Results - Earnings Call Transcript

Nektar: Reason Will Rarely Fail You

Nektar Therapeutics (NKTR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Re

Nektar Therapeutics (NKTR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

See More NKTR News...

NKTR's Top Competitors

NKTR $14.48 (1.54%)
Current stock: NKTR
TMO $122.72 (2.09%)
Current stock: TMO
ILMN $179.73 (0.21%)
Current stock: ILMN
WAT $103.88 (0.44%)
Current stock: WAT